Shopping Cart
Remove All
Your shopping cart is currently empty
XVA143 is an integrin α/β I-like allosteric antagonist that inhibits LFA-1 (αLβ2 integrin)-dependent firm adhesion and induces an extended conformation of integrins.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $249 | - | In Stock |
| Description | XVA143 is an integrin α/β I-like allosteric antagonist that inhibits LFA-1 (αLβ2 integrin)-dependent firm adhesion and induces an extended conformation of integrins. |
| In vitro | In the Mn²⁺ and Mg²⁺/EGTA systems, 1 μM XVA143 completely blocks the binding of ICAM-1 to LFA-1 without exhibiting any agonist activity [1]. XVA143 can restore the rolling function of the αL-E310A β2 mutant by inducing the extension of the αL Broussonetia papyrifera domain [2]. |
| Synonyms | XVA-143 |
| Molecular Weight | 562.36 |
| Formula | C25H21Cl2N3O8 |
| Cas No. | 264275-77-6 |
| Smiles | C(NCC1=CC(O)=CC=C1)(=O)C2=CC(Cl)=C(C(N[C@@H](CNC(=O)C3=CC(O)=CC(O)=C3)C(O)=O)=O)C(Cl)=C2 |
| Relative Density. | 1.550 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (142.26 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.